Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)

Brain MRI and neurocognitive characteristics of children and adolescents living with HIV

Collaborating to close gaps in Advanced HIV Disease (AHD) management in children

Penta’s 2024 Annual Report has been published!

ESPID Clinical Practice Guideline: Management of paediatric community-acquired pneumonia

Transforming trends: the changing landscape of infections in children over eight years

Mucosal immunity matters: salivary antibodies and cytokines are associated with disease severity in South African children hospitalized with acute respiratory infections

NeoSep1 trial launches to tackle drug-resistant sepsis in newborns

The effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household members

SARS-CoV-2 Infection Incidence and Severity in Immunocompromised Children: A Population-Based Study in Italy and Norway

EVOLUTION OF THE RESERVOIR IN EARLY TREATED CHILDREN WITH HIV-1 IN SUB-SAHARAN AFRICA

1 out of 20 children with HIV can achieve undetectable HIV-1 reservoir in Africa

BREATHER plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa

Clinical characteristics of COVID-19 in children and adolescents: insights from an Italian paediatric cohort using a machine-learning approach

Engagement and satisfaction of healthcare workers with online training in infection prevention, control, and antimicrobial stewardship: insights from the TEAM-COACH project

Clinical practice indicators for IPC and AMS in the pediatric population before and after participation in the pilot phase of a training project using an electronic tool (TEAM-COACH project)

Drivers of quasispecies development in SARS-CoV-2 and implications for emergent variants and COVID-19